Epidemic and endemic Kaposi's sarcoma: a comparison of outcomes and survival after radiotherapy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16019094.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We retrospectively studied the outcomes of 80 Epidemic and African-Endemic Kaposi's Sarcoma (EKS and AKS) patients treated with radiotherapy doses of 8.0 Gy. The objective response for EKS at one month was 74 and 58% for AKS while 5-year survival for EKS was 27 and 46% for AKS.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- Sarcoma, Kaposi
- Skin Neoplasms